Drawing for BIOPHORUM

USPTO serial 79263515

BIOPHORUM

Reviewed by CopyMark Law Group

Reg. 6093030Status 739Renewal
Filing date
Status date
Registration date
Jul 7, 2020
Examiner
MESSICK, TABITHA LEE
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with BIOPHORUM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $1,700

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Angela P. Doughty

Angela P. Doughty Ward and Smith, P.A.751 Corporate Center Drive, Suite 300Post Office Box 33009Raleigh, NC 27636-3009

Goods and services

ClassDescriptionStatusFirst use
016Printed matter, namely, books, reports, leaflets, pamphlets, flyers, articles, information sheets, manuals, newsletters, periodicals and journals all in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology or biopharmaceuticals; stationery; printed instructional and teaching materials all in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology or biopharmaceuticals; printed matter, namely, books, reports, leaflets, pamphlets, flyers, articles, information sheets, manuals, newsletters, periodicals and journals all in the biopharmaceutical field; printed matter, namely, books, reports, leaflets, pamphlets, flyers, articles, information sheets, manuals, newsletters, periodicals and journals all in the biotechnology field; research reports featuring biopharmaceutical and biotechnology dataACTIVE—
035Business development services; business advisory services relating to product development; business project management for others in the fields of biopharmaceuticals and biotechnology; business management consultancy; corporate business management consultancy; commercial management consultancy; business consultancy; business information; market research; business services, namely, formulation of best practices in the biopharmaceutical and biotechnology fields; expert evaluations and reports relating to business matters; business evaluation consultation services related to benchmarking programmes; providing business benchmarking information services; conducting business and market research surveys; collection of market research information; analysis of market research data and statistics; computerised market research services; preparation of business reports; provision of marketing reports; market reports and studies; promoting collaboration within the science and research communities; promoting collaboration within the science and research communities to achieve advances in the field of biopharmaceuticals and biotechnology; promoting the exchange of information within the science and research communities; promoting the exchange of information within the science and research communities to achieve advances in the field of biopharmaceuticals and biotechnology; business research; business research consultation; arranging and conducting business conferences; providing an in-person business forum in the fields of biopharmaceuticals and biotechnology; business consultancy to the biotechnology and biopharmaceuticals industry; business introduction services, namely, business networking; business project management services; business services, namely, organizing collaborative projects concerning business issues in the scientific, pharmaceutical, biopharmaceutical and biotechnology fields; arranging and conducting events, namely, organising business networking events in the field of life sciences, pharmaceuticals, biotechnology or biopharmaceuticalsACTIVE—
041Arranging and conducting seminars, workshops, educational conferences, teleconferences, webconferences and educational and entertainment events, all in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology or biopharmaceuticals; arranging and conducting seminars, workshops, educational conferences, teleconferences and educational and entertainment events all in the field of biotechnology and biopharmaceuticals; organisation of working groups, research groups and educational conventions all in the field of biopharmaceuticals and biotechnology; arranging and conducting meetings in the biopharmaceutical industry; arranging and conducting meetings in the biotech industry; arranging and conducting meetings to discuss best practices on a wide range of quality, engineering and organisational subjects within the biopharmaceutical and biotechnology fields; business training services; providing online training in the form of courses, seminars and workshops in the fields of biopharmaceuticals and biotechnology; providing an in-person educational forum in the fields of biopharmaceuticals and biotechnology; online, non-downloadable electronic newsletters in the fields of biopharmaceuticals and biotechnology; providing online newsletters in the field of biopharmaceuticals; providing online newsletters in the field of biotechnology; providing online reports in the field of biopharmaceuticals; providing online reports in the field of biotechnology; digital video, audio, and multimedia publishing services; digital video, audio, and multimedia publishing in relation to regulatory matters, scientific matters, business information, product development, product supply chain, biopharmaceuticals and biotechnology industry and technology; education services, namely, providing tutoring and training courses in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology or biopharmaceuticalsACTIVE—
042Scientific and technological services and research and design in the fields of biotechnology, medical technology, medical device and pharmaceutical research and development; industrial analysis and research services in the fields of biotechnology, medical device, medical technology, pharmaceutical research and development; technological consultancy in the field of biotechnology, pharmaceutical, medical technology and medical device research and development; scientific consultancy in the fields of biotechnology, pharmaceutical, life sciences, medical technology and medical device research and development; technical consultancy in the field of environmental science; product design and development in the field of biotechnology, pharmaceuticals, medical devices and medical technology; technology road-mapping, namely, technological services and technological consultancy to determine technological need, identify new technology or existing technology, model technological solutions, match technological solutions to technological need, and track the performance of technology; research services, namely, organizing collaborative research projects in the fields of biotechnology, pharmaceuticals, medical devices and medical technology; providing information in relation to life science, biopharmaceuticals and biotechnology; product quality evaluation; advisory services relating to the testing of safety of products; advisory services relating to the testing of safety of engineering products; advisory services relating to energy efficiency; advisory services relating to obtaining quality systems from organisations, namely, the documentation containing processes, procedures and responsibilities for achieving quality policies and objectives; auditing of the quality control capability of manufacturers; advisory services relating to quality control of manufactured goods; evaluation of quality performance of products against bench-mark references; project management of scientific research project; consultancy services, namely, organizing collaborative projects concerning scientific issues in the scientific, pharmaceutical, biopharmaceutical and biotechnology fieldsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 16, 2026NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Sep 16, 2026C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Sep 7, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 7, 2026ES75TEAS SECTION 71 & 15 RECEIVED—
Nov 29, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 7, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 21, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 3, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 3, 2020FIMPFINAL DISPOSITION PROCESSED—
Oct 7, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 7, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 21, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 21, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 1, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 17, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 17, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Mar 17, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 17, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 17, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 12, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 12, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 12, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 5, 2019RFNTREFUSAL PROCESSED BY IB—
Sep 16, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 16, 2019RFRRREFUSAL PROCESSED BY MPU—
Sep 8, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 7, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 5, 2019DOCKASSIGNED TO EXAMINER—
Jul 26, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 22, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 18, 2019SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance